[1] 《中国脑卒中防治报告2019》编写组.《中国脑卒中防治报告2019》概要[J].中国脑血管病杂志,2020,17(5): 272-281.
[2] Sun Yihong, Feng Lin, Li Xian,et al.The sex difference in 6-month MACEs and its explaining variables in acute myocardial infarction survivors: Data from CPACS-3 study[J]. Int J Cardiol,2020, 311: 1-6.
[3] Lu Yihua,Jiang Yun, Zhao Dongshen. Coronary artery disease in premenopausal and postmenopausal women[J]. Int Heart J, 2017, 58(2): 174-179.
[4] McSweeney J C,Rosenfeld A G,Abel W M, et al.Preventing and experiencing ischemic heart disease as a woman: state of the science: a scientific statement from the American Heart Association[J]. Circulation, 2016,133(13): 1302-1331.
[5] Hackshaw A, Morris J K,Boniface S,et al. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports[J]. BMJ, 2018,360: j5855.
[6] Ning Ding,Sang Yingying, Chen Jingsha,et al.Cigarette smoking, smoking cessation, and long-term risk of 3 major atherosclerotic diseases[J]. J Am Coll Cardiol, 2019, 74(4): 498-507.
[7] Szkup M,Jurczak A,Karakiewicz B et al.Influence of cigarette smoking on hormone and lipid metabolism in women in late reproductive stage[J]. Clin Interv Aging, 2018, 13: 109-115.
[8] Ruan X,Mueck A O. Impact of smoking on estrogenic efficacy[J]. Climacteric,2015,18(1): 38-46.
[9] 胡国良,刘 静,刘 军,等.吸烟与中青年女性急性冠状动脉综合征患者冠状动脉病变程度的关联研究[J].中华心血管病杂志,2020(5):378-385.
[10] Morris P B, Ference B A, Jahangir E, et al.Cardiovascular effects of exposure to cigarette smoke and electronic cigarettes: clinical perspectives from the prevention of cardiovascular disease section leadership council and early career councils of the American college of cardiology[J]. J Am Coll Cardiol, 2015, 66(12): 1378-1391.
[11] Garcia M, Mulvagh S L, Bairey Merz C N, et al. Cardiovascular disease in women: clinical perspectives[J]. Circ Res, 2016,118(8): 1273-1293.
[12] Peters S A E, Bots S H, Woodward M.Sex differences in the association between measures of general and central adiposity and the risk of myocardial infarction: results from the UK Biobank[J]. J Am Heart Assoc, 2018, 7(5): e008507.
[13] Kozakowski J, Gietka-Czernel M, Leszczyńska D, et al. Obesity in menopause-our negligence or an unfortunate inevitability? [J]. Prz Menopauzalny, 2017, 16(2): 61-65.
[14] Cervellati C, Bergamini C M. Oxidative damage and the pathogenesis of menopause related disturbances and diseases[J]. Clin Chem Lab Med, 2016, 54(5): 739-753.
[15] Thaung Zaw J J, Howe P R C, Wong R H X. Postmenopausal health interventions: time to move on from the Women’s Health Initiative? [J].Ageing Res Rev, 2018,48:79-86.
[16] Marchand G B, Carreau A M,Weisnagel S J,et al.Increased body fat mass explains the positive association between circulating estradiol and insulin resistance in postmenopausal women [J]. Am J Physiol Endocrinol Metab, 2018, 314(5): E448-e456.
[17] Millett E R C, Peters S A E, Woodward M, et al. Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants [J]. BMJ, 2018, 363: k4247.
[18] Saeed A,Ballantyne C M.Assessing cardiovascular risk and testing in Type 2 diabetes [J]. Curr Cardiol Rep, 2017, 19(3): 19.
[19] Appiah D,Winters S J,Muldoon S B,et al.Androgens, bilateral oophorectomy, and cardiovascular disease mortality in postmenopausal women with and without diabetes: the Study of osteoporotic fractures[J]. Diabetes Care, 2015, 38(12): 2301-2307.
[20] Selvin E,Lazo M,Chen Y,et al. Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage[J]. Circulation, 2014, 130(16):1374-1382.
[21] Ferranti E P, Jones E J, Hernandez T L.Pregnancy reveals evolving risk for?cardiometabolic disease in women[J]. J Obstet Gynecol Neonatal Nurs, 2016, 45(3): 413-425.
[22] Lo C C W, Lo A C Q, Leow S H, et al. Future cardiovascular disease risk for women with gestational hypertension: a systematic review and Meta-analysis[J]. J Am Heart Assoc, 2020, 9(13): e013991.
[23] Kramer C K,Campbell S,Retnakaran R.Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis[J]. Diabetologia, 2019,62(6): 905-914.
[24] Grand’Maison S, Pilote L, Schlosser K, et al. Clinical features and outcomes of acute coronary syndrome in women with previous pregnancy complications[J]. Can J Cardiol, 2017, 33(12): 1683-1692.
[25] Wu P, Haththotuwa R, Kwok C S, et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis[J]. Circ Cardiovasc Qual Outcomes, 2017,10(2):e003497.
[26] Liao K P. Cardiovascular disease in patients with rheumatoid arthritis[J]. Trends Cardiovasc Med, 2017, 27(2): 136-140.
[27] del Rincón I, Polak J F,O＇Leary D H,et al. Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis[J]. Ann Rheum Dis, 2015,74(6): 1118-1123.
[28] Zhang J, Chen L, Delzell E, et al. The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis[J]. Ann Rheum Dis, 2014, 73(7): 1301-1308.
[29] Ferketich A K,Schwartzbaum J A, Fird D J,et al. Depression as an antecedent to heart disease among women and men in the NHANES I study. National health and nutrition examination survey[J]. Arch Intern Med, 2000, 160(9):1261-1268.
[30] Champney K P, Frederick P D, Bueno H, et al. The joint contribution of sex, age and type of myocardial infarction on hospital mortality following acute myocardial infarction[J]. Heart, 2009, 95(11): 895-899.
[31] 中国医师协会心血管内科医师分会女医师工作委员会,中华医学会心血管病学分会女性心脏健康学组.中国女性心血管疾病预防专家共识[J].中华内科杂志, 2017(6): 472-476.
[32] Darby S C,Ewertz M,Mcgale P,et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer[J]. N Engl J Med, 2013, 368(11): 987-998.
[33] Beaton L, Bergman A, Nichol A, et al. Cardiac death after breast radiotherapy and the QUANTEC cardiac guidelines[J]. Clin Transl Radiat Oncol, 2019,19: 39-45.
[34] Piroth M D, Baumann R, Budach W, et al. Heart toxicity from breast cancer radiotherapy: current findings, assessment, and prevention[J]. Strahlenther Onkol, 2019, 195(1): 1-12.
[35] Grossman D C,Curry S J,Owens D K, et al. Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: US preventive services task force recommendation statement[J]. JAMA, 2017, 318(22):2224-2233.
[36] Huang A J, Sawaya G F, Vittinghoff E, et al. Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women[J]. Menopause, 2018, 25(11):1286-1290.
[37] Hu F B, Stampfer M J, Manson J E, et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women[J]. N Engl J Med, 2000, 343(8): 530-537.